THIRD ARC BIO, INC.

Profile

Company Names

THIRD ARC BIO, INC.

Addresses

727 NORRISTOWN ROAD, BLDG 8 SUITE 320, LOWER GWYNEDD, PA 19002

Phone Numbers

610-731-6021

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$72,499,974.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-07-16 
$72,499,974.00 
$164,999,939.00 
$92,499,965.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANCESCO 
 
DRAETTA 
DIRECTOR
BETA BIONICS, INC   |  OMEGA FUND VIII, L.P.   |  THIRD ARC BIO, INC.
JOSEPH 
 
ERHARDT 
EXECUTIVE OFFICER
THIRD ARC BIO, INC.
ARJUN 
 
GOYAL 
DIRECTOR
VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  SCORPION THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  THIRD ARC BIO, INC.   |  HALDA THERAPEUTICS, LLC   |  AFFINI-T THERAPEUTICS, INC.
PETER 
 
LEBOWITZ 
EXECUTIVE OFFICER, DIRECTOR
THIRD ARC BIO, INC.
OTELLO 
 
STAMPACCHIA 
DIRECTOR
OMEGA FUND III, L.P.   |  OMEGA FUND II, L.P.   |  TREVI THERAPEUTICS, INC.   |  MORPHIC HOLDING, LLC   |  ESSA PHARMA INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SCORPION THERAPEUTICS, INC.   |  IKENA ONCOLOGY, INC.   |  OMEGA FUND VIII, L.P.   |  THIRD ARC BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#